The Promise of Interleukin-2 Therapy 2019
November 13-16, 2019
Centre international de Conférence Sorbonne Université
The first meeting fully dedicated to biology and therapeutic use of IL-2.
Join us to hear more about deep immunophenotyping with Dura Innovation technology applied to low-dose IL-2 clinical trial immune monitoring and on our latest Dura Innovation panel development.
Click here to register.